The versatile functions of Sox9 in development, stem cells, and human diseases

Genes and Diseases

Volumn 1, Issue 2, 2014, Pages 149-161

  Jo, Alice ^a   Denduluri, Sahitya ^a   Zhang, Bosi ^a   Wang, Zhongliang ^a,b   Yin, Liangjun ^a,b   Yan, Zhengjian ^a,b   Kang, Richard ^a   Shi, Lewis L ^a   Mok, James ^a   Lee, Michael J ^a   Haydon, Rex C ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Development; Sox9; Stem cells; Transcription factor

Indexed keywords

TRANSCRIPTION FACTOR SOX9;

ALOPECIA AREATA; BONE DEVELOPMENT; CAMPOMELIC DYSPLASIA; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL MATURATION; CHONDROGENESIS; CONGENITAL DISORDER; DEVELOPMENTAL DISORDER; ECTODERM; EMBRYO DEVELOPMENT; ENDODERM; ENZYME MECHANISM; FIBROSIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; GONAD DEVELOPMENT; HAIR FOLLICLE; HEART VALVE; HEART VENTRICLE SEPTUM; HOMEOSTASIS; HUMAN; HUMAN DEVELOPMENT; HUMAN TISSUE; HYPERTRICHOSIS; INTESTINE; LIVER; LUNG; MESODERM; NEOPLASM; NEURAL CREST; NEURAL STEM CELL; ORGANOGENESIS; PANCREAS; PATHOGENESIS; PIGMENT EPITHELIUM; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; RETINA; RETINA PROGENITOR CELL; REVIEW; SCLEROSIS; SKIN PIGMENTATION; SPHINCTER; STEM CELL; XY GONADAL DYSGENESIS;

EID: 84978112122     PISSN: None     EISSN: 23523042     Source Type: Journal    
DOI: 10.1016/j.gendis.2014.09.004     Document Type: Review

References (140)

1. Simons B.D., Clevers H. Stem cell self-renewal in intestinal crypt. Exp Cell Res 2011, 317:2719-2724.
2. Rezza A., Sennett R., Rendl M. Adult stem cell niches: cellular and molecular components. Curr Top Dev Biol 2014, 107:333-372.
3. Gubbay J., Koopman P., Collignon J., Burgoyne P., Lovell-Badge R. Normal structure and expression of Zfy genes in XY female mice mutant in Tdy. Development 1990, 109:647-653.
4. Sinclair A.H., Berta P., Palmer M.S., et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990, 346:240-244.
5. Phochanukul N., Russell S. No backbone but lots of Sox: Invertebrate Sox genes. Int J Biochem Cell Biol 2010, 42:453-464.
6. Wagner T., Wirth J., Meyer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79:1111-1120.
7. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 1999, 27:1409-1420.
8. Finzsch M., Stolt C.C., Lommes P., Wegner M. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development 2008, 135:637-646.
9. Kellerer S., Schreiner S., Stolt C.C., Scholz S., Bosl M.R., Wegner M. Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence. Development 2006, 133:2875-2886.
10. Stolt C.C., Lommes P., Friedrich R.P., Wegner M. Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy. Development 2004, 131:2349-2358.
11. Huang W., Zhou X., Lefebvre V., de Crombrugghe B. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol 2000, 20:4149-4158.
12. Liu J.A., Wu M.H., Yan C.H., et al. Phosphorylation of Sox9 is required for neural crest delamination and is regulated downstream of BMP and canonical Wnt signaling. Proc Natl Acad Sci U S A 2013, 110:2882-2887.
13. Taylor K.M., Labonne C. SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation. Dev Cell 2005, 9:593-603.
14. Malki S., Boizet-Bonhoure B., Poulat F. Shuttling of SOX proteins. Int J Biochem Cell Biol 2010, 42:411-416.
15. Hattori T., Eberspaecher H., Lu J., et al. Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J Biol Chem 2006, 281:14417-14428.
16. Oh H.J., Kido T., Lau Y.F. PIAS1 interacts with and represses SOX9 transactivation activity. Mol Reprod Dev 2007, 74:1446-1455.
17. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009, 12:399-408.
18. Lu Y., Thomson J.M., Wong H.Y., Hammond S.M., Hogan B.L. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 2007, 310:442-453.
19. Miyaki S., Asahara H. Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 2012, 8:543-552.
20. Real F.M., Sekido R., Lupianez D.G., Lovell-Badge R., Jimenez R., Burgos M. A microRNA (mmu-miR-124) prevents Sox9 expression in developing mouse ovarian cells. Biol Reprod 2013, 89:78.
21. Hattori T., Kishino T., Stephen S., et al. E6-AP/UBE3A protein acts as a ubiquitin ligase toward SOX9 protein. J Biol Chem 2013, 288:35138-35148.
22. Kamachi Y., Uchikawa M., Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 2000, 16:182-187.
23. Bernard P., Tang P., Liu S., Dewing P., Harley V.R., Vilain E. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum Mol Genet 2003, 12:1755-1765.
24. Leung V.Y., Gao B., Leung K.K., et al. SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet 2011, 7:e1002356.
25. Ikeda T., Kamekura S., Mabuchi A., et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 2004, 50:3561-3573.
26. Sekido R., Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 2008, 453:930-934.
27. Alman B.A. Skeletal dysplasias and the growth plate. Clin Genet 2008, 73:24-30.
28. Thompson E.M., Matsiko A., Farrell E., Kelly D.J., O'Brien F.J. Recapitulating endochondral ossification: a promising route to invivo bone regeneration. J Tissue Eng Regen Med 2014, 10.1002/term.1918.
29. Hattori T., Muller C., Gebhard S., et al. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development 2010, 137:901-911.
30. Bell D.M., Leung K.K., Wheatley S.C., et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 1997, 16:174-178.
31. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997, 17:2336-2346.
32. Paul R., Haydon R.C., Cheng H., et al. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 2003, 28:755-763.
33. Akiyama H., Stadler H.S., Martin J.F., et al. Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. Matrix Biol 2007, 26:224-233.
34. St-Jacques B., Hammerschmidt M., McMahon A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999, 13(16):2072-2086.
35. Pritchett J., Harvey E., Athwal V., et al. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology 2012, 56:1108-1116.
36. Akiyama H. Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 2008, 18:213-219.
37. Topol L., Chen W., Song H., Day T.F., Yang Y. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 2009, 284:3323-3333.
38. Akiyama H., Lyons J.P., Mori-Akiyama Y., et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 2004, 18:1072-1087.
39. Sakai D., Suzuki T., Osumi N., Wakamatsu Y. Cooperative action of Sox9, Snail2 and PKA signaling in early neural crest development. Development 2006, 133:1323-1333.
40. Lee Y.H., Aoki Y., Hong C.S., Saint-Germain N., Credidio C., Saint-Jeannet J.P. Early requirement of the transcriptional activator Sox9 for neural crest specification in Xenopus. Dev Biol 2004, 275:93-103.
41. van Es J.H., Jay P., Gregorieff A., et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 2005, 7:381-386.
42. Foster J.W., Dominguez-Steglich M.A., Guioli S., et al. Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 1994, 372:525-530.
43. Huang B., Wang S., Ning Y., Lamb A.N., Bartley J. Autosomal XX sex reversal caused by duplication of SOX9. Am J Med Genet 1999, 87:349-353.
44. Sun D., Zhang Y., Wang C., Hua X., Zhang X.A., Yan J. Sox9-related signaling controls zebrafish juvenile ovary-testis transformation. Cell Death Dis 2013, 4:e930.
45. Wilhelm D., Hiramatsu R., Mizusaki H., et al. SOX9 regulates prostaglandin D synthase gene transcription invivo to ensure testis development. J Biol Chem 2007, 282:10553-10560.
46. Lasala C., Schteingart H.F., Arouche N., et al. SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1. Am J Physiol Endocrinol Metab 2011, 301:E539-E547.
47. Barrionuevo F., Georg I., Scherthan H., et al. Testis cord differentiation after the sex determination stage is independent of Sox9 but fails in the combined absence of Sox9 and Sox8. Dev Biol 2009, 327:301-312.
48. Oreal E., Pieau C., Mattei M.G., et al. Early expression of AMH in chicken embryonic gonads precedes testicular SOX9 expression. Dev Dyn 1998, 212:522-532.
49. Takada S., Mano H., Koopman P. Regulation of Amh during sexdetermination in chickens: Sox gene expression in maleand female gonads. Cell Mol Life Sci 2005, 62:2140-2146.
50. Akiyama H., Chaboissier M.C., Behringer R.R., et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci U S A 2004, 101:6502-6507.
51. Lincoln J., Kist R., Scherer G., Yutzey K.E. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol 2007, 305:120-132.
52. Pritchett J., Athwal V., Roberts N., Hanley N.A., Hanley K.P. Understanding the role of SOX9 in acquired diseases: lessons from development. Trends Mol Med 2011, 17:166-174.
53. Moniot B., Biau S., Faure S., et al. SOX9 specifies the pyloric sphincter epithelium through mesenchymal-epithelial signals. Development 2004, 131:3795-3804.
54. Theodosiou N.A., Tabin C.J. Sox9 and Nkx2.5 determine the pyloric sphincter epithelium under the control of BMP signaling. Dev Biol 2005, 279:481-490.
55. Martini S., Bernoth K., Main H., et al. A critical role for Sox9 in notch-induced astrogliogenesis and stem cell maintenance. Stem Cells 2013, 31:741-751.
56. Scott C.E., Wynn S.L., Sesay A., et al. SOX9 induces and maintains neural stem cells. Nat Neurosci 2010, 13:1181-1189.
57. Kang P., Lee H.K., Glasgow S.M., et al. Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis. Neuron 2012, 74:79-94.
58. Stolt C.C., Wegner M. SoxE function in vertebrate nervous system development. Int J Biochem Cell Biol 2010, 42:437-440.
59. Stolt C.C., Lommes P., Sock E., Chaboissier M.C., Schedl A., Wegner M. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev 2003, 17:1677-1689.
60. Sakai D., Wakamatsu Y. Regulatory mechanisms for neural crest formation. Cells Tissues Organs 2005, 179:24-35.
61. Cheung M., Briscoe J. Neural crest development is regulated by the transcription factor Sox9. Development 2003, 130:5681-5693.
62. Blanpain C., Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 2006, 22:339-373.
63. Vidal V.P., Chaboissier M.C., Lutzkendorf S., et al. Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr Biol 2005, 15:1340-1351.
64. Nowak J.A., Polak L., Pasolli H.A., Fuchs E. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell 2008, 3:33-43.
65. Poche R.A., Furuta Y., Chaboissier M.C., Schedl A., Behringer R.R. Sox9 is expressed in mouse multipotent retinal progenitor cells and functions in Muller glial cell development. J Comp Neurol 2008, 510:237-250.
66. Masuda T., Esumi N. SOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epithelium. J Biol Chem 2010, 285:26933-26944.
67. Zhu M.Y., Gasperowicz M., Chow R.L. The expression of NOTCH2, HES1 and SOX9 during mouse retinal development. Gene Expr Patterns 2013, 13:78-83.
68. Muto A., Iida A., Satoh S., Watanabe S. The group E Sox genes Sox8 and Sox9 are regulated by Notch signaling and are required for Muller glial cell development in mouse retina. Exp Eye Res 2009, 89:549-558.
69. Saint-Germain N., Lee Y.H., Zhang Y., Sargent T.D., Saint-Jeannet J.P. Specification of the otic placode depends on Sox9 function in Xenopus. Development 2004, 131:1755-1763.
70. Barrionuevo F., Naumann A., Bagheri-Fam S., et al. Sox9 is required for invagination of the otic placode in mice. Dev Biol 2008, 317:213-224.
71. Belo J., Krishnamurthy M., Oakie A., Wang R. The role of SOX9 transcription factor in pancreatic and duodenal development. Stem Cells Dev 2013, 22:2935-2943.
72. Seymour P.A., Freude K.K., Tran M.N., et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci U S A 2007, 104:1865-1870.
73. Piper K., Ball S.G., Keeling J.W., Mansoor S., Wilson D.I., Hanley N.A. Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. Mech Dev 2002, 116:223-226.
74. Seymour P.A., Freude K.K., Dubois C.L., Shih H.P., Patel N.A., Sander M. A dosage-dependent requirement for Sox9 in pancreatic endocrine cell formation. Dev Biol 2008, 323:19-30.
75. Shih H.P., Kopp J.L., Sandhu M., et al. A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation. Development 2012, 139:2488-2499.
76. Kawaguchi Y. Sox9 and programming of liver and pancreatic progenitors. J Clin Invest 2013, 123:1881-1886.
77. Carpino G., Cardinale V., Onori P., et al. Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages. J Anat 2012, 220:186-199.
78. Carpentier R., Suner R.E., van Hul N., et al. Embryonic ductal plate cells give rise to cholangiocytes, periportal hepatocytes, and adult liver progenitor cells. Gastroenterology 2011, 141(4). 1432-1438, 1438 e1431-1434.
79. Furuyama K., Kawaguchi Y., Akiyama H., et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 2011, 43:34-41.
80. Antoniou A., Raynaud P., Cordi S., et al. Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9. Gastroenterology 2009, 136:2325-2333.
81. Kodama Y., Hijikata M., Kageyama R., Shimotohno K., Chiba T. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 2004, 127:1775-1786.
82. Mori-Akiyama Y., van den Born M., van Es J.H., et al. SOX9 is required for the differentiation of paneth cells in the intestinal epithelium. Gastroenterology 2007, 133:539-546.
83. Bastide P., Darido C., Pannequin J., et al. Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol 2007, 178:635-648.
84. Shi Z., Chiang C.I., Mistretta T.A., Major A., Mori-Akiyama Y. SOX9 directly regulates IGFBP-4 in the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 2013, 305:G74-G83.
85. Mansour S., Hall C.M., Pembrey M.E., Young I.D. A clinical and genetic study of campomelic dysplasia. J Med Genet 1995, 32:415-420.
86. Perl A.K., Kist R., Shan Z., Scherer G., Whitsett J.A. Normal lung development and function after Sox9 inactivation in the respiratory epithelium. Genesis 2005, 41:23-32.
87. Chang D.R., Martinez Alanis D., Miller R.K., et al. Lung epithelial branching program antagonizes alveolar differentiation. Proc Natl Acad Sci U S A 2013, 110:18042-18051.
88. Rockich B.E., Hrycaj S.M., Shih H.P., et al. Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. Proc Natl Acad Sci U S A 2013, 110:E4456-E4464.
89. Turcatel G., Rubin N., Menke D.B., Martin G., Shi W., Warburton D. Lung mesenchymal expression of Sox9 plays a critical role in tracheal development. BMC Biol 2013, 11:117.
90. Masuda T., Wahlin K., Wan J., et al. Transcription factor SOX9 plays a key role in the regulation of visual cycle gene expression in the retinal pigment epithelium. J Biol Chem 2014, 289:12908-12921.
91. Cotsarelis G. Gene expression profiling gets to the root of human hair follicle stem cells. J Clin Invest 2006, 116:19-22.
92. Kadaja M., Keyes B.E., Lin M., et al. SOX9: a stem cell transcriptional regulator of secreted niche signaling factors. Genes Dev 2014, 28:328-341.
93. Aoki Y., Saint-Germain N., Gyda M., et al. Sox10 regulates the development of neural crest-derived melanocytes in Xenopus. Dev Biol 2003, 259:19-33.
94. Passeron T., Valencia J.C., Bertolotto C., et al. SOX9 is a key player in ultraviolet B-induced melanocyte differentiation and pigmentation. Proc Natl Acad Sci U S A 2007, 104:13984-13989.
95. Barker N., Clevers H. Tracking down the stem cells of the intestine: strategies to identify adult stem cells. Gastroenterology 2007, 133:1755-1760.
96. Blache P., van de Wetering M., Duluc I., et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 2004, 166:37-47.
97. Dorrell C., Erker L., Schug J., et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev 2011, 25:1193-1203.
98. Malato Y., Naqvi S., Schurmann N., et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 2011, 121:4850-4860.
99. Banga A., Akinci E., Greder L.V., Dutton J.R., Slack J.M. Invivo reprogramming of Sox9+ cells in the liver to insulin-secreting ducts. Proc Natl Acad Sci U S A 2012, 109:15336-15341.
100. Kopp J.L., Dubois C.L., Hao E., Thorel F., Herrera P.L., Sander M. Progenitor cell domains in the developing and adult pancreas. Cell Cycle 2011, 10:1921-1927.
101. Solar M., Cardalda C., Houbracken I., et al. Pancreatic exocrine duct cells give rise to insulin-producing beta cells during embryogenesis but not after birth. Dev Cell 2009, 17:849-860.
102. Mead T.J., Yutzey K.E. Notch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development. Proc Natl Acad Sci U S A 2009, 106:14420-14425.
103. Grogan S.P., Olee T., Hiraoka K., Lotz M.K. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site. Arthritis Rheum 2008, 58:2754-2763.
104. Deschaseaux F., Pontikoglou C., Sensebe L. Bone regeneration: the stem/progenitor cells point of view. J Cell Mol Med 2010, 14:103-115.
105. Paganelli M., Nyabi O., Sid B., et al. Downregulation of Sox9 expression associates with hepatogenic differentiation of human liver mesenchymal stem/progenitor cells. Stem Cells Dev 2014, 23:1377-1391.
106. Rockel J.S., Kudirka J.C., Guzi A.J., Bernier S.M. Regulation of Sox9 activity by crosstalk with nuclear factor-kappaB and retinoic acid receptors. Arthritis Res Ther 2008, 10:R3.
107. Ushita M., Saito T., Ikeda T., et al. Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells. Osteoarthritis Cartilage 2009, 17:1065-1075.
108. Sun L., Mathews L.A., Cabarcas S.M., et al. Epigenetic regulation of SOX9 by the NF-kappaB signaling pathway in pancreatic cancer stem cells. Stem Cells 2013, 31:1454-1466.
109. Pan Q., Yu Y., Chen Q., et al. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter. J Cell Physiol 2008, 217:228-241.
110. Zhao B., Etter L., Hinton R.B., Benson D.W. BMP and FGF regulatory pathways in semilunar valve precursor cells. Dev Dyn 2007, 236:971-980.
111. Xu X., Browning V.L., Odorico J.S. Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech Dev 2011, 128:412-427.
112. Govindarajan V., Overbeek P.A. FGF9 can induce endochondral ossification in cranial mesenchyme. BMC Dev Biol 2006, 6:7.
113. Chen Z., Huang J., Liu Y., et al. FGF signaling activates a Sox9-Sox10 pathway for the formation and branching morphogenesis of mouse ocular glands. Development 2014, 141:2691-2701.
114. Seymour P.A., Shih H.P., Patel N.A., et al. A Sox9/Fgf feed-forward loop maintains pancreatic organ identity. Development 2012, 139:3363-3372.
115. Desai B.M., Oliver-Krasinski J., De Leon D.D., et al. Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. J Clin Invest 2007, 117:971-977.
116. Dor Y., Brown J., Martinez O.I., Melton D.A. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
117. Houston C.S., Opitz J.M., Spranger J.W., et al. The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17-year-old boy first reported by Maroteaux, etal in 1971. Am J Med Genet 1983, 15:3-28.
118. Vidal V.P., Chaboissier M.C., de Rooij D.G., Schedl A. Sox9 induces testis development in XX transgenic mice. Nat Genet 2001, 28:216-217.
119. Garcia-Cruz D., Figuera L.E., Cantu J.M. Inherited hypertrichoses. Clin Genet 2002, 61:321-329.
120. Fantauzzo K.A., Kurban M., Levy B., Christiano A.M. Trps1 and its target gene Sox9 regulate epithelial proliferation in the developing hair follicle and are associated with hypertrichosis. PLoS Genet 2012, 8:e1003002.
121. Calvieri S., Rossi A. Alopecia in genetic diseases. Giornale italiano di dermatologia e venereologia: organo ufficiale, Societa italiana di dermatologia e sifilografia. 2014, 149:1-13.
122. Diehl A.M., Chute J. Underlying potential: cellular and molecular determinants of adult liver repair. J Clin Invest 2013, 123:1858-1860.
123. Hanley K.P., Oakley F., Sugden S., Wilson D.I., Mann D.A., Hanley N.A. Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 2008, 283:14063-14071.
124. Bennett M.R., Czech K.A., Arend L.J., Witte D.P., Devarajan P., Potter S.S. Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli. Nephron Exp Nephrol 2007, 107:e30-e40.
125. Sumi E., Iehara N., Akiyama H., et al. SRY-related HMG box 9 regulates the expression of Col4a2 through transactivating its enhancer element in mesangial cells. Am J Pathol 2007, 170:1854-1864.
126. Clemons N.J., Wang D.H., Croagh D., et al. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 2012, 303:G1335-G1346.
127. Drivdahl R., Haugk K.H., Sprenger C.C., Nelson P.S., Tennant M.K., Plymate S.R. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Oncogene 2004, 23:4584-4593.
128. Kato N., Fukase M., Motoyama T. Expression of a transcription factor, SOX9, in Sertoli-stromal cell tumors of the ovary. Int J Gynecol Pathol 2004, 23:180-181.
129. Miller S.J., Jessen W.J., Mehta T., et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. EMBO Mol Med 2009, 1:236-248.
130. Passeron T., Valencia J.C., Namiki T., et al. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest 2009, 119:954-963.
131. Sakamoto H., Mutoh H., Miura Y., Sashikawa M., Yamamoto H., Sugano K. SOX9 is highly expressed in nonampullary duodenal adenoma and adenocarcinoma in humans. Gut Liver 2013, 7:513-518.
132. Swartling F.J., Ferletta M., Kastemar M., Weiss W.A., Westermark B. Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 2009, 28:3121-3131.
133. Vidal V.P., Ortonne N., Schedl A. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms. J Cutan Pathol 2008, 35:373-379.
134. Wang H., Leav I., Ibaragi S., et al. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion. Cancer Res 2008, 68:1625-1630.
135. Wang H., McKnight N.C., Zhang T., Lu M.L., Balk S.P., Yuan X. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Cancer Res 2007, 67:528-536.
136. Thomsen M.K., Ambroisine L., Wynn S., et al. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res 2010, 70:979-987.
137. Schaeffer E.M., Marchionni L., Huang Z., et al. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer. Oncogene 2008, 27:7180-7191.
138. Alexaki V.I., Javelaud D., Van Kempen L.C., et al. GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst 2010, 102:1148-1159.
139. Gomez-Ospina N., Chang A.L., Qu K., Oro A.E. Translocation affecting sonic hedgehog genes in basal-cell carcinoma. N. Engl J Med 2012, 366:2233-2234.
140. Kopp J.L., von Figura G., Mayes E., et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 2012, 22:737-750.